The enrolled measure would define pharmacy practice to include several pharmacist care services and protect pharmacists who decline collaborative care agreements.
Pharmacy practice would include patient assessment, counseling, pharmacist care services, and collaborative care, with details set by pharmacy board rules.
Pharmacists would not have to join collaborative care agreements, and employers could not discriminate against pharmacists who decline them.
The measure would define pharmacy practice to include assessing patients to prescribe drugs and devices under board rules, pharmacist care services, patient counseling, and collaborative care. These provisions apply to people practicing pharmacy under the Wyoming Pharmacy Act. The board of pharmacy would govern pharmacist care services and collaborative pharmaceutical care through rules. The listed activities are examples and do not limit the broader definition of pharmacy practice. This provision would take effect July 1, 2026.
The measure would say pharmacists are not required to provide collaborative pharmaceutical care and employers may not discriminate against pharmacists who decline such agreements. The protection covers pharmacists and their employers when a pharmacist declines to participate in a collaborative pharmacy practice agreement. Collaborative pharmaceutical care would remain subject to pharmacy board rules. This provision would take effect July 1, 2026.
No hearings or votes scheduled.